T follicular helper (Tfh) cells are a subgroup of activated CD4 + T cells in the germinal centers of secondary lymphoid organs, they play critical roles in the development of many chronic autoimmune inflammatory diseases. The aim of this study was to investigate whether circulating Tfh cells contribute to the development of rheumatoid arthritis (RA).
Background:
T follicular helper (Tfh) cells are a subgroup of activated CD4 + T cells in the germinal centers of secondary lymphoid organs, they play critical roles in the development of many chronic autoimmune inflammatory diseases. The aim of this study was to investigate whether circulating Tfh cells contribute to the development of rheumatoid arthritis (RA).
Material/Methods:
Thirty patients fulfilled the diagnosis criteria that was established by the American College of Rheumatology and 30 healthy controls were recruited. The frequency of Tfh cells in patients and collagen-induced arthritis (CIA) in DBA/1J mice were analyzed by flow cytometry. The serum IL-21 level was examined by enzyme-linked immunosorbent assay (ELISA). The mRNA expression of Blimp-1 and Bcl-6 were detected by qRT-PCR.
Results:
RA patients had more CD4 + PD-1 + CXCR5 + Tfh cells in peripheral blood compared with healthy controls, and CIA in DBA/1J mice showed similar results. Higher mRNA expression of Bcl-6 and lower Blimp-1 mRNA expression were observed in patients with RA compared to healthy controls, and the expression level of IL-21 was higher in RA patients, which was also seen in CIA mice. Furthermore, the spleen CD4 
Conclusions:
The activated Tfh cells in the peripheral blood may be responsible for the development of RA.
Background
Rheumatoid arthritis (RA) is a systemic autoimmune disease accompanied by hyperplastic synovium, cartilage degradation, and bone destruction [1, 2] . It is identified by the presence of circulating auto-antibodies including anti-cyclic citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF) [3, 4] . Immunocompetent cells including B cells, T cells, dendritic cells, neutrophils, and natural killer cells, as well as soluble factors such as chemokines and cytokines, are thought to contribute to disease pathogenesis [5, 6] . Studies have demonstrated that CD4 + T cells and their secreted cytokines are important in the induction and aggravation of the inflammation [7, 8] .
Follicular helper T (Tfh) cells are a subgroup of CD4
+ T cells that are localized in the B-cell follicle [9, 10] . With the help of CD4 + T cells, activated B cells migrate into lymphoid follicles of lymphoid organs and generate germinal centers, differentiating into plasma cells that secrete RF, ACPA, and other autoreactive antibodies [11, 12] . Tfh cells are defined by the expression of transcription factor B-cell lymphoma 6 (BCL-6), surface molecules including CD40 ligand, chemokine (C-X-C) receptor 5 (CXCR5), programmed cell death protein-1 (PD-1), inducible T-cell co-stimulator (ICOS), and cytokines such as interleukin (IL)-21, IL-6 and IL-10 [13, 14] . Blimp-1 is a transcription factor that acts as an antagonist of BCL-6. The fate of Tfh cell differentiation is dependent on the balance between BCL-6 and Blimp-1 in T cells [15] . It is well-known that uncontrolled generation of Tfh cells in the germinal centers or peripherals could contribute to autoimmunity diseases such as systemic lupus erythematosus and type 1 diabetes, however, the potential role of Tfh cells in the progress of rheumatoid arthritis is not well known [16] [17] [18] .
In the present study, we investigated whether circulating Tfh cells contribute to the development of RA. We found increased Tfh cells in the peripheral blood of RA patients and collageninduced arthritis (CIA) mice, and there are close correlations between the increase of Tfh cells, and IL-21, serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), RF, and ACPA in RA patients. 
Material and Methods

Chemicals
Patients
There were 30 patients with new-onset RA (<6 months of disease duration) in accordance with the diagnosis criteria established by the American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) [19] , who were admitted by the Rheumatology Department of the General Hospital of Ningxia Medical University from November 2016 to February 2018. Thirty healthy controls with matched gender and age were recruited from the same hospital. RA patients were not included in the study if they received treatment of steroids, biological disease-modifying antirheumatic drugs, methotrexate, sulfasalazine, or leflunomide in the past 6 months, or if they had other chronic inflammatory and autoimmune diseases. The collection of peripheral blood of health controls and RA patients was approved by the Ethics Committee of the Ningxia Medical University (No.2015-111). Description of the patients are shown in Table 1 .
Animals
Male DBA/1J mice (18-22 g) were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Permit Number: 201708981). They had free access to food and water, and they were housed in multilayer laminar flow racks under a controlled environment (20-25°C and 12-hour light: dark cycle). This study was conducted according to the "Guiding Principles for the Care and Use of Laboratory Animals" [20] and all programs by the Animal Care and Use Committee of Ningxia Medical University. ESR -erythrocyte sedimentation rate; CRP -C-reactive protein; ACPA -anti-cyclic citrullinated peptide antibodies; RF -rheumatoid factor.
Establishment of CIA
We used 0.1 mL of bovine type II collagen in an emulsion with complete Freund's adjuvant (1: 1, v/v) to inject subcutaneously into the tail (at approximately 2 cm from the base of the tail) of male DBA/1J mice (8 weeks old) mice [21] . After 21 days, 0.1 mL of collagen emulsion in the same concentrations as the first immunization, substituting CFA for IFA in incomplete Freund's adjuvant (1: 1, v/v) were injected into the tail of the mouse closer to the base of the tail than the original injection site. The control mice were treated in the same way without the CII antigen. The progression of CIA in DBA/1J mice were assessed every 3 days between day 1 and day 45. Erythema, swelling, and scleroma were examined and graded in each paw, and the 4 scores were summed so that the maximum possible score was 16 per mouse. The score was calculated at 5-point scale [8] : 0 was normal, no redness and inflammation; 1 was swelling and redness in one digit; 2 was signs involving the ankle plus tarsal of the hind paw and/or wrist plus carpals of the fore paw; 3 was swelling and redness in all digits and joints; 4 was severe disease involving the entire hind or fore paw.
Histological analysis of knee joints
On day 45 after the first injection, DBA/1J mice were sacrificed after anesthesia and serum samples were collected. Knee joints were fixed in 10% neutral buffered formalin solution for 24 hours and then decalcified in 10% ethylene diamine tetraacetate (EDTA) for 30 days with the EDTA solution renewed once a week, followed by embedding in paraffin. 3-μm thick sections were stained with hematoxylin and eosin (H&E).
Biochemical and immunological measurements
Peripheral venous blood samples involved K2-EDTA blood samples were obtained from individual participants, the values of ESR, the serum levels of CRP, RF, and ACPA were measured by scatter turbidimetry (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany) in the clinical laboratory of the General Hospital of Ningxia Medical University.
Measurement of serum IL-21
IL-21 in RA patients and healthy controls serum was determined by ELISA according to the manufacturer's instructions. To measure IL-21 in mice, DBA/1J mice were sacrificed on the final day of experimentation and then the serum was collected. The absorbance at 450 nm was then detected by an ELISA reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA), and plotted against a standard curve with standard levels expressed as pg/mL. Each sample was examined in triplicate.
Spleen lymphocyte preparation
DBA/1J mice spleens were placed in phosphate-buffered saline (PBS) immediately after sacrifice and mechanically disrupted through a wire mesh strainer with the end of a 10 mL plastic syringe plunger. Cell debris were removed from cell suspensions by filter through lens tissue. After centrifugation at 800 rpm/minute for 5 minutes at 4°C, cells were resuspended and dispersed in trypsin followed counting using a hemocytometer.
RNA purification and real-time quantitative PCR analysis
Total RNA of peripheral blood mononuclear cells (PBMCs) was purified by TRIzol. Reverse transcription kit was used to synthesize complementary DNA (cDNA). Real-time quantitative PCR was performed as following: 95°C for 2 minutes, 40 cycles at 95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 45 seconds. Primers used for the PCR were: BCL-6: sense, 5'-ACCAGAATGCCAAACCAGAG-3', and antisense, 5'-TCAAGGTTCTCAGGCTCCAT-3'; Blimp-1: sense, 5'-AGCAGCGACGAAGCCATGAATC-3' and antisense, 5'-TGCACTCTCAGGTGGACCTTCAG-3'. The relative mRNA expression was calculated using the 2 DDCq method [22] , and normalized using b-actin as the reference gene.
Flow cytometry analysis
Blood was density-gradient centrifugated using 
Statistical analyses
Data were analyzed using the mean ± standard deviation. Figure 2D, 2E) . To further prove our results, the collagen-induced arthritis in DBA/1J mice model was established. As shown in Figure 3A and 3B, there were a significant increase in hind paw volume and the arthritic scores in the CIA mice group compared to the normal control (P<0.05) ( Figure 3A, 3B ). Histopathological examination of the knee joints by H&E staining revealed remarkable synovial hyperplasia, inflammatory cell infiltration into the joint capacity of CIA mice compared with the normal control mice ( Figure 3C, 3D) . Flow cytometry analysis showed that the percentage of CD4 + CXCR5 + ICOS + Tfh cells in CIA mice were significantly higher than those in the control mice ( Figure 4A) , and the level of IL-21 in the serum of CIA mice was higher than those of the control mice (P<0.01) (Figure 4B ), suggesting that increased frequency of activated Tfh cells in the RA mouse model, which further supports our results from RA patients. These data indicate that IL-21 produced by Tfh cells might contribute to the development of RA. The balance between BCL-6 and Blimp-1 plays a critical role in Tfh cell differentiation. To further examine whether Tfh cells in RA patients are important for RA pathogenesis, the mRNA expression of Bcl-6 and Blimp-1 in RA patients and healthy controls were examined by qRT-PCR. The results showed that Bcl-6 mRNA expression of RA patients was higher than that in healthy controls ( Figure 5A ) while the level of Blimp-1 mRNA was decreased in RA patients ( Figure 5B ).
Discussion
Rheumatoid arthritis is an autoimmune disease which is char- and ACPAs. It is known that the production of antibodies is caused by interaction between T-B cells. Tfh cells are a novel subpopulation of CD4 + T cells that are specialized in the germinal centers of secondary lymphoid organs, where they promoted B cell functional differentiation and maturation and sustained antibody production in the periphery [23, 24] . Data have shown that the number of CD4 + ICOS + T cells increased in the peripheral blood of patients with systemic lupus erythematosus (SLE) and myasthenia gravis (MG) [25, 26] . In this study, we found significant increased frequency of CD4 + CXCR5
+ PD-1 + circulating Tfh cells in the peripheral blood of RA patients. Tfh cell numbers are important for germinal center B cell survival and affinity maturation, however, excessive Tfh cells have the potential to drive aberrant germinal center B-cell survival, possibly due to the generation of autoantibodies to establish autoimmune disease.
Bcl-6 is an essential transcription factor for Tfh cells; it regulates Tfh cells differentiation and maturation [27] . Blimp-1 is 3038 an antagonist of Bcl-6, it limits the differentiation of T cells into Tfh cells. The expression of Bcl-6 is dependent on IL-6 and IL-21; it can identify Tfh cells from other polarized T helper cell subsets as well [28, 29] . IL-21 is the hallmark cytokine of Tfh cells and it acts as a potent inducer of plasma cell and induces the secretion of IgG, IgM, and IgA [30] . Some previous studies have demonstrated that increased frequency of Tfh cells correlated with higher levels of serum IL-21 in RA patients compared with healthy controls, and the increased concentration of IL-21 could promoted the mRNA expression of Bcl-6 [31, 32] . In this study, we found upregulated Bcl-6 mRNA expression and downregulated Blimp-1 mRNA expression in RA patients, indicating an increase in T cell differentiation into Tfh cells in RA patients. Our results revealed significant high serum IL-21 in the RA patients. Moreover, the serum concentration of RF, ACPA, ESR, and CRP was also associated with the IL-21 which can be produced by Tfh cells. These data suggested that Tfh cells might contribute to the pathogenesis of RA. 
Conclusions
Our research data suggested that the circulating Tfh cells were involved in the pathological progression of RA and the percentage of circulating Tfh cells was a valuable biomarker of the uncontrolled responses of antibodies in RA. However, the activation mechanisms of Tfh cells, and how IL-21 regulates B cell and Tfh cell activation and differentiation in RA patients, needs to be further explored in the future.
